Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 1
2012 3
2013 3
2014 8
2015 6
2016 1
2017 7
2018 6
2019 3
2020 3
2021 9
2022 9
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Informed Consent.
Afolabi MO, García-Basteiro AL. Afolabi MO, et al. N Engl J Med. 2017 May 18;376(20):e43. doi: 10.1056/NEJMc1704010. N Engl J Med. 2017. PMID: 28517925 No abstract available.
Addressing the challenges of implementing evidence-based prioritisation in global health.
Hayman DTS, Barraclough RK, Muglia LJ, McGovern V, Afolabi MO, N'Jai AU, Ambe JR, Atim C, McClelland A, Paterson B, Ijaz K, Lasley J, Ahsan Q, Garfield R, Chittenden K, Phelan AL, Lopez Rivera A. Hayman DTS, et al. Among authors: afolabi mo. BMJ Glob Health. 2023 Jun;8(6):e012450. doi: 10.1136/bmjgh-2023-012450. BMJ Glob Health. 2023. PMID: 37290897 Free PMC article. Review.
Informed consent comprehension in African research settings.
Afolabi MO, Okebe JU, McGrath N, Larson HJ, Bojang K, Chandramohan D. Afolabi MO, et al. Trop Med Int Health. 2014 Jun;19(6):625-642. doi: 10.1111/tmi.12288. Epub 2014 Mar 17. Trop Med Int Health. 2014. PMID: 24636078 Free article. Review.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Among authors: afolabi mo. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Manno D, Ayieko P, Ishola D, Afolabi MO, Rogers B, Baiden F, Serry-Bangura A, Bah OM, Köhn B, Swaray I, Owusu-Kyei K, Otieno GT, Kowuor D, Tindanbil D, Smout E, Robinson C, Keshinro B, Foster J, Gallagher K, Lowe B, Douoguih M, Leigh B, Greenwood B, Watson-Jones D. Manno D, et al. Among authors: afolabi mo. Emerg Infect Dis. 2022 Mar;28(3):734-738. doi: 10.3201/eid2803.211496. Emerg Infect Dis. 2022. PMID: 35202536 Free PMC article.
64 results